Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13420)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 24, 2022 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lubián López DM. Management of genitourinary syndrome of menopause in breast cancer survivors: An update. World J Clin Oncol 2022; 13(2): 71-100 [PMID: 35316932 DOI: 10.5306/wjco.v13.i2.71] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v13/i2/71.htm |
| Number | Citing Articles |
| 1 |
Ishrat Hussain, Vikram Sinai Talaulikar. A systematic review of randomised clinical trials – The safety of vaginal hormones and selective estrogen receptor modulators for the treatment of genitourinary menopausal symptoms in breast cancer survivors. Post Reproductive Health 2023; 29(4): 222 doi: 10.1177/20533691231208473
|
| 2 |
Manon Mangiardi-Veltin, Delphine Hequet, Carine Segura-Djezzar, Roman Rouzier, Claire Bonneau. Sexuality after breast cancer, how to provide a global and contemporary approach. Bulletin du Cancer 2023; 110(1): 113 doi: 10.1016/j.bulcan.2022.10.002
|
| 3 |
Aniele Tomadon, Jaqueline Lemos de Oliveira, Isabella Queren de Oliveira, Thais de Oliveira Gozzo. Genitourinary symptoms and quality of life of women with breast cancer undergoing chemotherapy. Fisioterapia e Pesquisa 2023; 30 doi: 10.1590/1809-2950/e23001823en
|
| 4 |
Serpil Abalı Çetin. Managing Side Effects of Breast Cancer Treatment. 2024; : 331 doi: 10.1007/978-3-031-75480-7_25
|
| 5 |
Pranjal Agrawal, Sajya M. Singh, Corey Able, Kathryn Dumas, Jaden Kohn, Taylor P. Kohn, Marisa Clifton. Safety of Vaginal Estrogen Therapy for Genitourinary Syndrome of Menopause in Women With a History of Breast Cancer. Obstetrics & Gynecology 2023; 142(3): 660 doi: 10.1097/AOG.0000000000005294
|
| 6 |
Franklin José Espitia De La Hoz. Eficacia y seguridad del promestrieno en el tratamiento del síndrome genitourinario de la menopausia en mujeres con cáncer de mama. Universitas Médica 2024; 65 doi: 10.11144/Javeriana.umed65.espt
|
| 7 |
Maddalena Mallozzi. Vaginal treatment with solid state non ablative laser 1470 nm for vaginal atrophy in post menopausal women. Laser Therapy 2023; 30(1) doi: 10.4081/ltj.2023.320
|
| 8 |
Vittoria Benini, Alessandro Ruffolo, Arianna Casiraghi, Rebecca Degliuomini, Matteo Frigerio, Andrea Braga, Maurizio Serati, Marco Torella, Massimo Candiani, Stefano Salvatore. New Innovations for the Treatment of Vulvovaginal Atrophy: An Up-to-Date Review. Medicina 2022; 58(6): 770 doi: 10.3390/medicina58060770
|
| 9 |
Solveig K. Smedsland, Kathrine F. Vandraas, Ragnhild S. Falk, Julie Horn, Randi J. Reidunsdatter, Cecilie E. Kiserud, Alv A. Dahl, Mette Brekke, Kristin V. Reinertsen. Sexual health in long-term breast cancer survivors: a comparison with female population controls from the HUNT study. Breast Cancer Research and Treatment 2023; 201(3): 479 doi: 10.1007/s10549-023-07021-y
|
| 10 |
Mekan R. Orazov, Elena S. Silantyeva, Viktor E. Radzinsky, Liudmila M. Mikhaleva, Elizaveta A. Khripach, Evgeny D. Dolgov. Efficacy of laser remodeling in the genitourinary syndrome of menopause: A review. Gynecology 2023; 24(6): 465 doi: 10.26442/20795696.2022.6.201897
|
| 11 |
S. Salvatore, A. F. Ruffolo, C. Phillips, S. Athanasiou, L. Cardozo, M. Serati. Vaginal laser therapy for GSM/VVA: where we stand now – a review by the EUGA Working Group on Laser. Climacteric 2023; 26(4): 336 doi: 10.1080/13697137.2023.2225766
|
| 12 |
Laura Cucinella, Lara Tiranini, Chiara Cassani, Silvia Martella, Rossella E Nappi. Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Current Perspectives on the Role of Laser Therapy. International Journal of Women's Health 2023; : 1261 doi: 10.2147/IJWH.S414509
|
| 13 |
Daniel M. Lubián-López, Carmen A. Butrón-Hinojo, Salomón Menjón-Beltrán, Ernesto González-Mesa, Silvia Tapiador-Albertos, Bibiana Rodríguez-Jiménez, Gabriel Fiol-Ruiz. Effects of Non-Ablative Solid-State Vaginal Laser (SSVL) for the Treatment of Vulvovaginal Atrophy in Breast Cancer Survivors after Adjuvant Aromatase Inhibitor Therapy: Preliminary Results. Journal of Clinical Medicine 2023; 12(17): 5669 doi: 10.3390/jcm12175669
|
| 14 |
Mária Faltinová, Leena Vehmanen, Heli Lyytinen, Hanna Savolainen-Peltonen, Anni Virtanen, Mikko Haanpää, Esa Hämäläinen, Aila Tiitinen, Johanna Mattson. Effects of vaginal estrogen on serum estradiol during aromatase inhibitor therapy in breast cancer patients with vulvovaginal atrophy: a prospective trial. Breast Cancer Research and Treatment 2024; doi: 10.1007/s10549-024-07564-8
|
| 15 |
J. K. K. Mark, S. Samsudin, I. Looi, K. H. Yuen. Vaginal dryness: a review of current understanding and management strategies. Climacteric 2024; 27(3): 236 doi: 10.1080/13697137.2024.2306892
|
| 16 |
Rossella E. Nappi, Silvia Martella, Francesca Albani, Chiara Cassani, Ellis Martini, Fabio Landoni. Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors?. Healthcare 2022; 10(8): 1528 doi: 10.3390/healthcare10081528
|
| 17 |
Lotti Lúcia Lőczi, Gábor Vleskó, Máté Éliás, Caner Turan, Panna Kajtár, Réka Tóth, Miklós Sipos, Rita Nagy, Péter Hegyi, Nándor Ács, Szabolcs Várbíró, Márton Keszthelyi. Effect of Vaginal Laser and Topical Therapies on Vulvovaginal Atrophy Symptoms in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2024; 13(20): 6131 doi: 10.3390/jcm13206131
|
| 18 |
Caroline Nakano Vitorino, Michelle Sako Omodei, Rafaela Caroline de Souza, Georgia Petri Nahas, Daniel de Araujo Brito Buttros, Eduardo Carvalho-Pessoa, Heloisa De Luca Vespoli, Eliana Aguiar Petri Nahas. Assessment of sexual function in postmenopausal breast cancer survivors. Sexual Medicine 2024; 12(3) doi: 10.1093/sexmed/qfae035
|
| 19 |
Qiancheng Mao, Tong Cai, Haijuan Li, Yongli Chu, Yuanshan Cui, Jitao Wu. The efficacy of CO2 laser in the treatment of genitourinary syndrome of menopause: a systematic review and meta-analysis of randomized controlled trials. Lasers in Medical Science 2023; 38(1) doi: 10.1007/s10103-023-03808-z
|
| 20 |
Gilbert G.G. Donders, Francesca H.W.V. Donders. New developments in the management of vulvovaginal atrophy: a comprehensive overview. Expert Opinion on Pharmacotherapy 2023; 24(5): 599 doi: 10.1080/14656566.2023.2194017
|
| 21 |
Nobuo Okui. Vaginal Laser Treatment for the Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Narrative Review. Cureus 2023; doi: 10.7759/cureus.45495
|
| 22 |
Feng Jing, Zheng Zhu, Jiajia Qiu, Lichen Tang, Lei Xu, Weijie Xing, Yan Hu. Symptom Clusters and Quality of Life in Patients With Breast Cancer Receiving Endocrine Therapy in China. Seminars in Oncology Nursing 2023; 39(4): 151443 doi: 10.1016/j.soncn.2023.151443
|
| 23 |
Bernadeta A. Pietrzak, Agnieszka Wnuk, Karolina Przepiórska, Andrzej Łach, Małgorzata Kajta. Posttreatment with Ospemifene Attenuates Hypoxia- and Ischemia-Induced Apoptosis in Primary Neuronal Cells via Selective Modulation of Estrogen Receptors. Neurotoxicity Research 2023; 41(4): 362 doi: 10.1007/s12640-023-00644-5
|
| 24 |
Linda Cucciniello, Federica Miglietta, Valentina Guarneri, Fabio Puglisi. Managing sexual health challenges in breast cancer survivors: A comprehensive review. The Breast 2024; 76: 103754 doi: 10.1016/j.breast.2024.103754
|
| 25 |
Mary E. Beste, Andrew M. Kaunitz, Jordan A. McKinney, Luis Sanchez-Ramos. Vaginal estrogen use in breast cancer survivors: a systematic review and meta-analysis of recurrence and mortality risks. American Journal of Obstetrics and Gynecology 2024; doi: 10.1016/j.ajog.2024.10.054
|
| 26 |
Maliheh Arab, Mahshid Vasef, Maryam Talayeh, Maryam Sadat Hosseini, Farah Farzaneh, Tahereh Ashrafganjoei. The Effect of Radiofrequency Therapy on Sexual Function in Female Cancer Survivors (Gynecologic and Breast) and Non-cancer Menopausal Women: A Single-Arm Trial. Journal of Lasers in Medical Sciences 2023; 14: e32 doi: 10.34172/jlms.2023.32
|
| 27 |
Nida Jugulytė, Guoda Žukienė, Daiva Bartkevičienė. Emerging Use of Vaginal Laser to Treat Genitourinary Syndrome of Menopause for Breast Cancer Survivors: A Review. Medicina 2023; 59(1): 132 doi: 10.3390/medicina59010132
|
| 28 |
Gabriela C. Cantarelli, Ana M.H.M. Bianchi-Ferraro, Chayanne Dedonatto, Marcela F.R. Fernandes, Rafaela B. Vanzin, Rita C.M. Dardes, Angela F. Logullo, Joaquim S. de Almeida, Gil Facina, Zsuzsanna I.K. de Jármy-Di Bella, Marair G.F. Sartori, Marisa T. Patriarca. Clinical and histomorphometric evaluation of the vagina following treatment with CO2 laser, radiofrequency, and promestriene for genitourinary syndrome of menopause in breast cancer survivors on adjuvant therapy. Maturitas 2025; 191: 108155 doi: 10.1016/j.maturitas.2024.108155
|
| 29 |
Lucia Merlino, Giulia D’Ovidio, Viviana Matys, Maria Grazia Piccioni, Maria Grazia Porpora, Roberto Senatori, Maria Federica Viscardi, Antonio Vitale, Carlo Della Rocca. Therapeutic Choices for Genitourinary Syndrome of Menopause (GSM) in Breast Cancer Survivors: A Systematic Review and Update. Pharmaceuticals 2023; 16(4): 550 doi: 10.3390/ph16040550
|
| 30 |
Gaetano Perrini, Silvia Actis, Margherita Giorgi, Francesca Accomasso, Carola Minella, Cristina Fava, Giorgia Bisconte, Giovanni De Rosa, Annamaria Ferrero, Valentina Elisabetta Bounous. Assessment of the Efficacy and Safety of a Dual-Wavelength Diode Laser System for the Treatment of Vulvovaginal Atrophy in Women Without a History of Breast Cancer and in Patients with a History of Breast Cancer. Journal of Clinical Medicine 2025; 14(3): 801 doi: 10.3390/jcm14030801
|
| 31 |
Risa Kagan, James A. Simon, Steven R. Goldstein, Barry S. Komm, Simon N. Jenkins, David J. Portman. Oral lasofoxifene's effects on moderate to severe vaginal atrophy in postmenopausal women: two phase 3, randomized, controlled trials. Menopause 2024; 31(6): 494 doi: 10.1097/GME.0000000000002355
|
| 32 |
Stefano Salvatore, Vittoria Benini, Alessandro Ferdinando Ruffolo, Rebecca S. Degliuomini, Anna Redaelli, Arianna Casiraghi, Massimo Candiani. Current challenges in the pharmacological management of genitourinary syndrome of menopause. Expert Opinion on Pharmacotherapy 2023; 24(1): 23 doi: 10.1080/14656566.2022.2152326
|
| 33 |
Svetlana Jankovic, Marija Rovcanin, Ana Tomic, Aleksandar Jurisic, Zagorka Milovanovic, Milena Zamurovic. Understanding the Benefits of CO2 Laser Treatment for Vulvovaginal Atrophy. Medicina 2024; 60(7): 1059 doi: 10.3390/medicina60071059
|
| 34 |
Shari B. Goldfarb, Sarah L. Sammons, Jane L. Meisel, Timothy J. Pluard, Simon N. Jenkins, Barry S. Komm, Dominic Carroll, David J. Portman. Effects of Lasofoxifene Versus Fulvestrant on Vaginal and Vulvar Symptoms in Patients With ESR1-Mutated, ER+/HER2-, Metastatic Breast Cancer From the ELAINE 1 Study. Clinical Breast Cancer 2024; doi: 10.1016/j.clbc.2024.12.002
|
| 35 |
Pierre Marès, Camille Jauffret, Carine Martin, Patrice Lopes, Florence Coussy. Genitourinary syndrome of menopause in patients with breast cancer treated by hormonotherapy: women's perception in ITAC, a French web-based survey. Bulletin du Cancer 2024; 111(4): 347 doi: 10.1016/j.bulcan.2023.08.014
|
| 36 |
Lauren F. Streicher. Diagnosis, causes, and treatment of dyspareunia in postmenopausal women. Menopause 2023; 30(6): 635 doi: 10.1097/GME.0000000000002179
|
| 37 |
Haixiao Wen, Chong Lu, Meng Zhang, Xingling Qi. A real-world disproportionality analysis of ospemifene: data mining of the public version of FDA adverse event reporting system. Expert Opinion on Drug Safety 2023; 22(11): 1133 doi: 10.1080/14740338.2023.2247971
|
| 38 |
Penny Kechagioglou, Nina Fuller-Shavel. Integrative Oncology in Breast Cancer Care. 2023; : 63 doi: 10.1007/978-3-031-51216-2_8
|
| 39 |
Victoria Kershaw, Swati Jha. Practical Guidance on the Use of Vaginal Laser Therapy: Focus on Genitourinary Syndrome and Other Symptoms. International Journal of Women's Health 2024; : 1909 doi: 10.2147/IJWH.S446903
|
| 40 |
Nobuo Okui, Machiko Okui, Yuko Kouno, Kaori Nakano, Marco Gambacciani. Efficacy of Two Laser Treatment Strategies for Breast Cancer Survivors With Genitourinary Syndrome of Menopause. Cureus 2023; doi: 10.7759/cureus.38604
|
| 41 |
Aniele Tomadon, Jaqueline Lemos de Oliveira, Isabella Queren de Oliveira, Thais de Oliveira Gozzo. Sintomas geniturinários e qualidade de vida de mulheres com câncer de mama em tratamento quimioterápico. Fisioterapia e Pesquisa 2023; 30 doi: 10.1590/1809-2950/e23001823pt
|
| 42 |
Annabelle Huguenin. Menopausal hormone therapy for breast cancer survivors. Current Opinion in Obstetrics & Gynecology 2025; 37(1): 37 doi: 10.1097/GCO.0000000000001001
|
| 43 |
Yueh‐Ching Lee, Yuan‐Ching Chang, Cheng‐Chen Chou, Yen‐Kuang Lin, Chia‐Hui Li, Yuan‐Mei Liao. Psychometric Evaluation of the Chinese Version of the Vulvovaginal Symptom Questionnaire in Women With Breast Cancer. Journal of Advanced Nursing 2024; doi: 10.1111/jan.16584
|
| 44 |
Isaac Melo MD, Dolores Escobedo MSN, Karla Aguilar MD, Wendy Aguilar MD, Yazzmin Ballesteros MD, Carlos Durazo MD, Omar Guerrero MD. Treatment of sexual dysfunction, with platelet rich plasma in woman cancer survivors. Obstetrics & Gynecology International Journal 2024; 15(3): 122 doi: 10.15406/ogij.2024.15.00746
|
| 45 |
S. Palacios. Sequential treatment in vulvovaginal atrophy. Climacteric 2023; 26(4): 292 doi: 10.1080/13697137.2023.2197588
|
| 46 |
Vera N. Prilepskaya, Niso M. Nazarova, Anastasia R. Devyatkina, Patimat R. Abakarova, Elena A. Mezhevitinova. Potential and perspectives of local application of hyaluronic acid in vulvovaginal atrophy in women of reproductive age: A review. Gynecology 2024; 26(3): 254 doi: 10.26442/20795696.2024.3.202932
|